News

Navigating CVS Health: Insights from the Options Market

Navigating CVS Health: Insights from the Options Market

Understanding CVS Health Options Market Dynamics

Investors are observing notable bearish activity surrounding CVS Health (NYSE: CVS). This trend is crucial for retail traders to consider.

Recent Options Trading Activity

Today, the options market revealed an unusual 9 trades involving CVS Health. This spike is not considered ordinary, suggesting that significant investors may have insider insights.

The current sentiment among professional traders indicates a predominance of bearish positions, with 66% expressing a lack of confidence in CVS's short-term performance. The data showed only 22% of investors holding bullish views. Among the trades analyzed, a single put option accounted for $34,260, whereas 8 call options reached a total of $498,984.

Projected Price Movements

Based on these activities, many larger stakeholders are speculating a price range for CVS Health between $40.00 and $87.50 over the next three months.

Trends in Volume and Open Interest

The mean open interest for CVS options today stands at around 4,565.56 with a total trading volume of approximately 2,029. Understanding these dynamics is essential for evaluating market movements.

A detailed analysis shows how the volume and the open interest for CVS Health’s options have evolved within the critical price band over the last month.

Recent Options Activity Overview: Last 30 Days

Investors have noticed several significant transactions worth tracking. Below are some key trades from the past month that exemplify broader market sentiment:

Significant Options Trades:

SymbolPUT/CALLTrade TypeSentimentExpiration DateAskBidPriceStrike PriceTotal Trade PriceOpen InterestVolume
CVSCALLTRADEBEARISH02/20/26$2.05$1.94$1.95$87.50$234.0K411.2K
CVSCALLSWEEPBEARISH01/16/26$14.35$12.75$13.09$65.00$57.5K4.1K44
CVSCALLSWEEPBULLISH03/20/26$4.8$4.75$4.8$80.00$48.0K18.7K136
CVSCALLTRADEBEARISH12/18/26$38.75$37.5$37.5$40.00$37.5K6370
CVSPUTSWEEPBEARISH11/21/25$1.64$1.64$1.64$76.00$34.2K680200

About CVS Health

CVS Health is a leading provider of a range of healthcare services, with its foundation in retail pharmacy. Operating more than 9,000 stores in the U.S., CVS also serves as a significant pharmacy benefit manager—processing around 2 billion adjusted claims each year. Additionally, its health insurance arm reaches approximately 27 million medical members. A recent acquisition of Oak Street Health has diversified its offerings, adding primary care which complements its existing services.

Current Standing of CVS Health

As of now, CVS has a trading volume of 3,446,706 shares. The stock price has decreased slightly by 0.38%, bringing it to $76.40. The Relative Strength Index (RSI) values indicate that the stock is currently in a neutral territory, balancing between overbought and oversold conditions. Investors are keenly awaiting the next earnings report scheduled in approximately 103 days.

Analyst Perspectives on CVS Health

Analysts have provided insights and ratings on CVS Health, noting a consensus target price of $94.0. The ratings vary, with a notable analyst from UBS maintaining a Buy rating at $96, while Truist Securities downgraded its rating but kept a new price target of $95. Furthermore, RBC Capital retained its Outperform rating at $93 and Evercore ISI also maintained an Outperform rating at $95. However, Goldman Sachs has taken a cautious approach, downgrading to a Buy rating with a target of $91.

Risk and Reward in Options Trading

Trading options poses a higher risk compared to stock trading, yet it can also deliver substantial rewards. Successful options traders enhance their strategies by acquiring knowledge daily, incrementally engaging with trades, and utilizing multiple indicators while closely monitoring market conditions.

Frequently Asked Questions

What is the current sentiment surrounding CVS Health?

The current sentiment is largely bearish with 66% of major traders expressing concerns about CVS's performance.

What price range are investors anticipating for CVS Health in the coming months?

Investors are expecting a price range between $40.00 and $87.50 over the next three months.

How is CVS Health performing in the stock market?

CVS Health's stock has seen a slight decline, currently priced at $76.40.

What is the general analyst outlook on CVS Health?

Analysts have a consensus target price around $94.0, indicating a mixed outlook among brokers.

What factors make options trading riskier?

Options trading is riskier due to its complex nature and the potential for quick losses, requiring traders to be well-informed and cautious.

About The Author

About Investors Hangout

Investors Hangout is a leading online stock forum for financial discussion and learning, offering a wide range of free tools and resources. It draws in traders of all levels, who exchange market knowledge, investigate trading tactics, and keep an eye on industry developments in real time. Featuring financial articles, stock message boards, quotes, charts, company profiles, and live news updates. Through cooperative learning and a wealth of informational resources, it helps users from novices creating their first portfolios to experts honing their techniques. Join Investors Hangout today: https://investorshangout.com/

The content of this article is based on factual, publicly available information and does not represent legal, financial, or investment advice. Investors Hangout does not offer financial advice, and the author is not a licensed financial advisor. Consult a qualified advisor before making any financial or investment decisions based on this article. This article should not be considered advice to purchase, sell, or hold any securities or other investments. If any of the material provided here is inaccurate, please contact us for corrections.

Top 10 Most Recent News Articles

ST Engineering iDirect, MBSat Forge Middle East Satellite Hub

Updated Category News Views 294

Satellite Services Take Off in the Middle East Never thought the day would come where the Middle East is on the threshold of leapfrogging satellite tech, but here we are. ST Engineering iDirect just locked arms with MBSat—yep, that's part of the Mohammed Al Barwani Group—to birth a next-gen satellite connectivity service hub in Oman and across surrounding areas....

Continue Reading
Monster Energy Unleashes Gaming Frenzy at Cosm L.A. Event

Updated Category News Views 152

Where Energy Drinks and Digital Reality Collide Monster Energy sure knows how to throw a party, especially when it hinges on something as electrifying as Call of Duty: Modern Warfare 4. Imagine this: Cosm Los Angeles is decked out with a massive 87-foot LED dome, and every gamer, celeb, and influencer ready to dive right in. You can't make this stuff up. They've mashed...

Continue Reading
RYBREVANT's Promising Results in HNSCC Treatment

Updated Category News Views 138

Impressive Outcomes for RYBREVANT FASPRO in Head and Neck Cancer Tucked away in the endless cycle of drug trials, a glimmer of hope shines through with new data on RYBREVANT FASPRO in treating head and neck squamous cell carcinoma (HNSCC). This science talk might not rattle the ticker tape directly on NYSE:JNJ, but it has all the makings of a game-changer in the oncology...

Continue Reading
TORRAS Cases Balance Protection with Slim Design for 2026

Updated Category News Views 218

Are Slim iPhone Cases Really Protecting Your Investment? Anyone who's dropped a brand-new phone knows the pain of watching your investment smack the concrete. But hey, welcome to 2026, where Consumer365's latest rundown on iPhone protective gear turns the spotlight on TORRAS. These folks grabbed attention with their Q3 Air and Q3 Air Pro cases, crafted for iPhone 18 Pro...

Continue Reading
Tennessee's Bold Lung Cancer Trial Signals Innovation

Updated Category News Views 119

The Heartbeat of Innovation in Cancer Therapy Who would've thought Tennessee would be at the forefront of a global push against lung cancer? Sure, there's Nashville's music scene, but it's the researchers at Tennessee Oncology who are grooving to a different beat—one that might just set the rhythm for advanced cancer therapies worldwide. Yeah, it's a trial, but not just...

Continue Reading
Air Sealing First: Boosting Home Comfort & Efficiency

Updated Category News Views 157

Everyone wants a cozy, energy-efficient home, right? Well, the first step to achieving that might just surprise you. Forget about shoving more insulation into the walls for a second; air sealing should be your starting line. That's the drum Insulation Expert Mike Mancuso is beating, and he's got a point worth considering before you touch another insulation panel. Cracking...

Continue Reading
Dr. Boonipat Inspires Future Women Surgeons at Texas Tech

Updated Category News Views 75

Sowing Surgical Seeds in Lubbock In Lubbock, Texas, something meaningful unfolded—an event the big market players would hardly blink at, but a significant step for the future of medicine. Led by Dr. Thanapoom "Mo" Boonipat, the founder of FacePlus Plastic Surgery Institute, a unique suturing workshop provided premed students at Texas Tech University hands-on experience...

Continue Reading
Ivonescimab Promises New Hope for Advanced BTC Patients

Updated Category News Views 289

Shifting the Paradigm in Biliary Tract Cancer Treatment Here's the scoop from the bustling world of oncology: the trial of Ivonescimab plus chemotherapy is stirring waves among experts in advanced biliary tract cancer (BTC). Contrary to the usual drowsy mornings with coffee and market pages, this data from Hong Kong wasn't about Wall Street this time. This trial might...

Continue Reading
Community in Shock After Fatal Bakersfield Shooting

Updated Category News Views 136

The Ripple Effect of Tragedy Grief has a way of shaking a community down to its core—especially when the loss emanates from such senseless violence as the shooting death of 17-year-old Levi Brown. This wasn't just a tragic occurrence at a Friday night football game in Bakersfield; it was a visceral crack in the perceived safety of community events. Levi's Legacy and...

Continue Reading
Hims & Hers Faces FTC Heat: Investor Class Action Looms

Updated Category News Views 206

Trouble Is Brewing for Hims & Hers Investors This isn't your typical quiet stroll through the park when it comes to Hims & Hers Health, Inc. (NYSE: HIMS). We're talking about a full-blown legal showdown that's unfolding faster than you can say 'telehealth scandal.' October 25, 2026, saw the kind of announcement that makes seasoned investors' hearts skip a beat if they've...

Continue Reading

Top 5 Most Recently Viewed Articles

Sobi's Share Increase and Its Impact on Business Growth

Updated Category News Views 202

Sobi's Growth through Share Increases In a recent announcement, Swedish Orphan Biovitrum AB (publ) has revealed a significant increase in its total number of shares and votes. As of the latest update, the total number of shares amounts to 357,412,837, including 356,000,049 common shares and 1,412,788 class C shares. This increase in shares is primarily attributed to the...

Continue Reading
Hain Celestial's Q1 Results Show Improvement Despite Losses

Updated Category News Views 116

Hain Celestial Group Reports Strong Fiscal First Quarter Results Hain Celestial Group, Inc. (NASDAQ: HAIN), a prominent global health and wellness company, has recently shared its financial performance for the first quarter of the fiscal year. Despite facing challenges, the company indicates a clear trajectory towards recovery and improvement in its business operations....

Continue Reading
Orca Energy Group Provides Key Updates on Operations and Finances

Updated Category News Views 181

Overview of Orca Energy Group's Operational Update Orca Energy Group Inc. (TSX-V: ORC.A, ORC.B) is excited to announce significant updates regarding its operations and financial performance. The company, which operates in natural gas development, continues its focus on the production and supply of gas in Tanzania through its subsidiary, PanAfrican Energy Tanzania Limited....

Continue Reading
Annexon Encourages Growth with Employee Stock Options Grant

Updated Category News Views 153

Annexon Supports New Talent with Inducement Grants In a recent move to bolster its workforce, Annexon, Inc. (Nasdaq: ANNX), a prominent biopharmaceutical company, has made strides in attracting top talent by offering inducement grants to new employees. This is part of their 2022 Employment Inducement Award Plan. The grant is designed to empower its workforce while...

Continue Reading
Don Johnson Receives FAA Wright Brothers Master Pilot Award

Updated Category News Views 320

Honoring Aviation Excellence: FAA Award for Don Johnson Prime Jet, a leader in private jet charters and aircraft management, proudly announces a significant accomplishment of one of its renowned pilots. Don Johnson has been awarded the prestigious Wright Brothers Master Pilot Award by the Federal Aviation Administration (FAA). This distinguished honor is extended to...

Continue Reading